Product Name: JARDIANCE®
Active Ingredient: Empagliflozin
Manufacturers: Boehringer Ingelheim and Eli Lilly and Company
Strength: 25 mg
Presentation: Box containing 30 film-coated tablets.

Product Description

JARDIANCE® contains empagliflozin, a sodium-glucose co-transporter-2 (SGLT2) inhibitor used to improve glycemic control in adults with type 2 diabetes mellitus. It is also used in certain patients to reduce cardiovascular and kidney-related risks according to approved indications.

Packaging Appearance

• Branded JARDIANCE® pharmaceutical carton.
• Front panel typically displays:
  • JARDIANCE®
  • Empagliflozin 25 mg
  • 30 film-coated tablets
• Tablets are usually oval-shaped and film-coated.

Pack Contents

• 30 × film-coated tablets
• Each tablet contains 25 mg empagliflozin
• Oral administration

Administration

• Taken orally, usually once daily.
• May be taken with or without food as directed by a healthcare professional.

Storage

• Store at room temperature in the original packaging.
• Protect from excessive moisture and heat.
• Keep out of reach of children.

Catalog Alt Text

“JARDIANCE® 25 mg empagliflozin, box containing 30 film-coated tablets manufactured by Boehringer Ingelheim and Eli Lilly for the treatment of type 2 diabetes mellitus.”